OGX-427 in Metastatic Castrate-Resistant Prostate Cancer With Prostate-Specific Antigen Progression While Receiving Abiraterone
Clinical trial NCT01681433 · TERMINATED
Trial details
- NCT number
- NCT01681433
- Sponsor
- Costantine Albany
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-01
- Primary completion
- 2017-06-21
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.